[HTML][HTML] Peptidomimetics in cancer targeting
The low efficiency of treatment strategies is one of the main obstacles to developing cancer
inhibitors. Up to now, various classes of therapeutics have been developed to inhibit cancer …
inhibitors. Up to now, various classes of therapeutics have been developed to inhibit cancer …
[HTML][HTML] Molecular imaging of bone metastasis
E Khojasteh, F Dehdashti, M Shokeen - Journal of Bone Oncology, 2023 - ncbi.nlm.nih.gov
Recent advances in molecularly targeted modular designs for in vivo imaging applications
has thrusted open possibilities of investigating deep molecular interactions non-invasively …
has thrusted open possibilities of investigating deep molecular interactions non-invasively …
Biodistribution and radiation dosimetry in cancer patients of the ascorbic acid analogue 6-Deoxy-6-[18F] fluoro-L-ascorbic acid PET imaging: first-in-human study
Y Long, C Yi, R Wu, Y Zhang, B Zhang, X Shi… - European Journal of …, 2023 - Springer
Purpose Clinical studies on the use of ascorbic acid (AA) have become a hot spot in cancer
research. There remains an unmet need to assess AA utilization in normal tissues and …
research. There remains an unmet need to assess AA utilization in normal tissues and …
[HTML][HTML] Targeted imaging of very late antigen-4 for noninvasive assessment of lung inflammation-fibrosis axis
Q Zhu, CE Barnes, PZ Mannes, JD Latoche, KE Day… - EJNMMI research, 2023 - Springer
Background The lack of noninvasive methods for assessment of dysregulated inflammation
as a major driver of fibrosis (ie, inflammation-fibrosis axis) has been a major challenge to …
as a major driver of fibrosis (ie, inflammation-fibrosis axis) has been a major challenge to …
Biodistribution, Dosimetry, and Pharmacokinetics of 68Ga-CBP8: A Type I Collagen–Targeted PET Probe
The 68Ga-Collagen Binding Probe# 8, 68Ga-CBP8, is a peptide-based, type I collagen–
targeted probe developed for imaging of tissue fibrosis. The aim of this study was to …
targeted probe developed for imaging of tissue fibrosis. The aim of this study was to …
Effect of the type of N-substituent in the benzo-18-azacrown-6 compound on copper (ii) chelation: complexation, radiolabeling, stability in vitro, and biodistribution in …
LS Zamurueva, BV Egorova, IS Ikonnikova… - Dalton …, 2023 - pubs.rsc.org
In this work, we synthesized two new benzo-18-azacrown-6 ethers bearing picolinate and
pyridine pendant arms and studied the copper complexes of these ligands, as well as those …
pyridine pendant arms and studied the copper complexes of these ligands, as well as those …
[HTML][HTML] Molecular Imaging of Fibrosis in Benign Diseases: An Overview of the State of the Art
Y Zhang, W Huang, H Jiao, L Song, L Kang - Pharmaceuticals, 2024 - mdpi.com
Fibrosis is a progressive pathological process participating in the progression of many
diseases and can ultimately result in organ malfunction and failure. Around 45% of deaths in …
diseases and can ultimately result in organ malfunction and failure. Around 45% of deaths in …
[HTML][HTML] Current and Future PET Imaging for Multiple Myeloma
M Ishibashi, M Takahashi, T Yamaya, Y Imai - Life, 2023 - mdpi.com
Positron emission tomography (PET) is an imaging modality used for the noninvasive
assessment of tumor staging and response to therapy. PET with 18F labeled …
assessment of tumor staging and response to therapy. PET with 18F labeled …
[HTML][HTML] Molecular imaging of bone metastasis
E Khojasteh, F Dehdashti, M Shokeen - Journal of Bone Oncology, 2023 - Elsevier
Recent advances in molecularly targeted modular designs for in vivo imaging applications
has thrusted open possibilities of investigating deep molecular interactions non-invasively …
has thrusted open possibilities of investigating deep molecular interactions non-invasively …
Development of a PET-Based Theranostic for Drug-Resistant BRAFV600EMelanoma
MC Bellavia - 2023 - search.proquest.com
Targeted radiopharmaceutical therapy (TRT) involving systemic administration of a tumor-
selective agent labeled with a radionuclide has demonstrated considerable promise for …
selective agent labeled with a radionuclide has demonstrated considerable promise for …